- New Purchases: IVV, FB,
- Added Positions: AMGN, BMY, BWA, SLV, CVS, JPST, T, BK, INTC, K, GLD,
- Reduced Positions: ON, DISCA, AMAT, MSM, PDCO, AMZN, SCHW, CAJ, ZBH, AVY, CHS, WY, XOM,
- Sold Out: PG,
For the details of Biechele Royce Advisors's stock buys and sells, go to https://www.gurufocus.com/guru/biechele+royce+advisors/current-portfolio/portfolio
These are the top 5 holdings of Biechele Royce Advisors- Applied Materials Inc (AMAT) - 132,658 shares, 8.95% of the total portfolio. Shares reduced by 1.87%
- Apple Inc (AAPL) - 113,317 shares, 6.99% of the total portfolio. Shares reduced by 1%
- BorgWarner Inc (BWA) - 243,250 shares, 5.69% of the total portfolio. Shares added by 2.29%
- Amgen Inc (AMGN) - 43,480 shares, 5.46% of the total portfolio. Shares added by 90.84%
- CVS Health Corp (CVS) - 133,271 shares, 5.06% of the total portfolio. Shares added by 1.54%
Biechele Royce Advisors initiated holding in iShares Core S&P 500 ETF. The purchase prices were between $368.98 and $397.82, with an estimated average price of $385.98. The stock is now traded at around $409.130000. The impact to a portfolio due to this purchase was 0.4%. The holding were 2,000 shares as of 2021-03-31.
New Purchase: Facebook Inc (FB)Biechele Royce Advisors initiated holding in Facebook Inc. The purchase prices were between $245.64 and $294.53, with an estimated average price of $269.28. The stock is now traded at around $303.410100. The impact to a portfolio due to this purchase was 0.11%. The holding were 730 shares as of 2021-03-31.
Added: Amgen Inc (AMGN)Biechele Royce Advisors added to a holding in Amgen Inc by 90.84%. The purchase prices were between $221.91 and $258.6, with an estimated average price of $238.59. The stock is now traded at around $252.530000. The impact to a portfolio due to this purchase was 2.6%. The holding were 43,480 shares as of 2021-03-31.
Added: Bristol-Myers Squibb Company (BMY)Biechele Royce Advisors added to a holding in Bristol-Myers Squibb Company by 137.61%. The purchase prices were between $59.34 and $66.74, with an estimated average price of $62.18. The stock is now traded at around $64.820000. The impact to a portfolio due to this purchase was 2.37%. The holding were 128,810 shares as of 2021-03-31.
Added: JPMorgan Ultra-Short Income ETF (JPST)Biechele Royce Advisors added to a holding in JPMorgan Ultra-Short Income ETF by 48.59%. The purchase prices were between $50.69 and $50.78, with an estimated average price of $50.74. The stock is now traded at around $50.715000. The impact to a portfolio due to this purchase was 0.06%. The holding were 7,385 shares as of 2021-03-31.
Added: SPDR Gold Shares ETF (GLD)Biechele Royce Advisors added to a holding in SPDR Gold Shares ETF by 37.74%. The purchase prices were between $157.49 and $182.87, with an estimated average price of $168.06. The stock is now traded at around $170.510000. The impact to a portfolio due to this purchase was 0.04%. The holding were 1,595 shares as of 2021-03-31.
Sold Out: Procter & Gamble Co (PG)Biechele Royce Advisors sold out a holding in Procter & Gamble Co. The sale prices were between $122.15 and $140.16, with an estimated average price of $130.43.
Here is the complete portfolio of Biechele Royce Advisors. Also check out:
1. Biechele Royce Advisors's Undervalued Stocks
2. Biechele Royce Advisors's Top Growth Companies, and
3. Biechele Royce Advisors's High Yield stocks
4. Stocks that Biechele Royce Advisors keeps buying